Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Hans-Peter Stoll, MD, PHD
CONTACT
Amy Berman, MPH
CONTACT
Lead
Orchestra BioMed, Inc
The Virtue® ISR trial is a prospective, multi-center, single-blind, randomized (1:1), non-inferiority study. The Virtue® Sirolimus AngioInfusion™ Balloon (SAB) will be compared to the AGENT Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted